2021
Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice A Case Series
Bittl J, Bangalore S, DiMaio J, Grant M, Lawton J, Holland J. Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice A Case Series. JACC Case Reports 2021, 4: 31-35. PMID: 35036940, PMCID: PMC8743811, DOI: 10.1016/j.jaccas.2021.09.025.Peer-Reviewed Original ResearchACC/AHA/SCAI GuidelineCoronary artery revascularizationArtery revascularizationCase seriesStable ischemic heart diseaseA Case SeriesOptimal medical therapyComplex coronary diseaseSubset of patientsIschemic heart diseaseCardiovascular eventsVentricular dysfunctionCoronary diseaseMedical therapyHeart diseaseRevascularizationDiseaseGuidelinesPatientsDysfunctionTherapyMortality
2009
A Randomized Clinical Trial Investigating the Relationship Between Aprotinin and Hypercoagulabilityin Off-Pump Coronary Surgery
Desai P, Kurian D, Thirumavalavan N, Desai S, Ziu P, Grant M, White C, Landis R, Poston R. A Randomized Clinical Trial Investigating the Relationship Between Aprotinin and Hypercoagulabilityin Off-Pump Coronary Surgery. Anesthesia & Analgesia 2009, 109: 1387-1394. PMID: 19843776, PMCID: PMC2789288, DOI: 10.1213/ane.0b013e3181b81068.Peer-Reviewed Original ResearchMeSH KeywordsAprotininBlood CoagulationBlood Coagulation TestsBlood PlateletsCoronary Artery Bypass, Off-PumpDouble-Blind MethodErythrocyte TransfusionFibrinolytic AgentsGraft Occlusion, VascularHumansPeptide FragmentsPlatelet AdhesivenessPlatelet AggregationPlatelet Function TestsPostoperative HemorrhageProspective StudiesProthrombinReceptor, PAR-1ThrombinThrombosisTreatment OutcomeWound HealingConceptsMajor adverse cardiovascular eventsProtease-activated receptor 1Adverse cardiovascular eventsSaphenous vein graftsCardiovascular eventsOPCAB surgeryAprotinin groupCoronary sinusHypercoagulable stateVein graftsThrombin generationAntifibrinolytic propertiesPump coronary artery bypass surgeryOff-pump coronary surgeryCoronary artery bypass surgeryRed blood cell transfusionAprotinin-treated patientsFull-dose regimenArtery bypass surgeryBlood cell transfusionCoronary sinus bloodPAR-1 antagonistsPlatelet-leukocyte conjugatesPAR-1 activationPlatelet-derived microparticles